Amarin Corp Plc (AMRN)

[Bouf]

TT—I’m telling you what to expect from the generics brief. Their main point will be that it was up to the trial judge to decide which expert was more credible, because the trial judge heard the testimony. Appellate courts are not in the business of deciding based on a paper transcript which expert is more credible. That said, factual findings have to support a legal conclusion, and that is where AMRN has room to run here.